Skip to main content
OpenTrials

Clinical trial condition

Hypertension

Explore clinical trials studying Hypertension. Study availability and eligibility vary by location and protocol.

4,652 public trials 455 recruiting studies
Refine in advanced search Browse all conditions

Hypertension trial results

Completed

Combination of Telmisartan 80 mg Plus Hydrochlorothiazide 12.5 mg to Telmisartan 80 mg in Patients Failed in Telmisartan 80 mg

NCT00146341

Conditions
Cardiovascular Diseases, Hypertension, Vascular Diseases
Locations
  • China-Japan Friendship Hospital Beijing, China
  • Beijing Tiantan Hospital Beijing, China
  • Peking Union Medical College Hospital Beijing, China
  • No. 1 Hospital Affiliated Nanjing Nanjing, China
View Trial Details
Completed

Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension

NCT00168779

Conditions
Cardiovascular Diseases, Hypertension, Vascular Diseases
Locations
  • 502.476.074 Boehringer Ingelheim Investigational Site Athens, Alabama, United States
  • 502.476.059 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 502.476.071 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 502.476.079 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
View all 113 locations
View Trial Details
Completed

Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension

NCT00281593

Conditions
Cardiovascular Diseases, Hypertension, Vascular Diseases
Locations
  • 1236.1.511 Boehringer Ingelheim Investigational Site Glendale, Arizona, United States
  • 1236.1.574 Boehringer Ingelheim Investigational Site Tempe, Arizona, United States
  • 1236.1.501 Boehringer Ingelheim Investigational Site Tucson, Arizona, United States
  • 1236.1.557 Boehringer Ingelheim Investigational Site Tucson, Arizona, United States
View all 119 locations
View Trial Details
Completed

Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5

NCT00239369

Conditions
Cardiovascular Diseases, Hypertension, Vascular Diseases
Locations
  • Boehringer Ingelheim Investigational Site Birker?d, Denmark
  • Boehringer Ingelheim Investigational Site Haderslev, Denmark
  • Boehringer Ingelheim Investigational Site Odder, Denmark
  • Boehringer Ingelheim Investigational Site R?dovre, Denmark
View all 84 locations
View Trial Details

Related conditions